The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Sterile Compounding Pharmacies Market During The Forecast Period 2026–2030?
The market size for sterile compounding pharmacies has shown significant expansion in recent years. Projections indicate it will advance from $5.62 billion in 2025 to $5.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. The historical rise can be ascribed to factors including the growth in injectable therapies, increased hospital pharmacy demand, more stringent regulatory enforcement, developments in oncology drug compounding, and the necessity for specialty medication needs.
The sterile compounding pharmacies market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $7.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. The expansion during the forecast period is primarily driven by factors such as the growth of biologic drugs, the rise of personalized injectable therapies, existing hospital capacity constraints, the increased adoption of automation, and the evolving regulatory standards. Key developments expected within this period encompass the outsourcing of sterile compounding services, the implementation of advanced cleanroom technologies, greater automation in compounding processes, enhanced batch-level traceability, and investments spurred by compliance requirements.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12073&type=smp
Which Economic Or Industry Drivers Are Impacting The Sterile Compounding Pharmacies Market?
The sterile compounding pharmacies market is anticipated to expand due to the rising need for personalized medicine. This refers to medical approaches that prevent, diagnose, or treat illnesses by utilizing an individual’s genetic or protein data. Such pharmacies are crucial for delivering tailored medications within a sterile setting, ensuring customized treatments that align with patient requirements and mitigating potential intolerances to specific doses or drug formulations. This approach enhances treatment outcomes and boosts patient satisfaction and compliance with therapeutic regimens. As an illustration, the Personalized Medicine Coalition, a US-based non-profit organization, reported in February 2024 that the FDA had approved 16 new personalized treatments for rare diseases in 2023, marking a notable rise from the six approvals in 2022. Consequently, the growing demand for personalized medicine is a key factor propelling the sterile compounding pharmacies market.
What Market Segments Are Evaluated Within The Sterile Compounding Pharmacies Market?
The sterile compounding pharmacies market covered in this report is segmented –
1) By Product: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route Of Administrations: Intravenous, Intramuscular, Subcutaneous
4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary
Subsegments:
1) By Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels
3) By Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts
4) By Otic: Otic Solutions, Otic Suspensions, Otic Gels
How Are Trends Shaping The Direction Of The Sterile Compounding Pharmacies Market?
Leading firms within the sterile compounding pharmacies market are prioritizing technological innovations, particularly robotic automation, to improve the safety, efficiency, and capacity of sterile compounding procedures. These robotic automation systems incorporate sophisticated monitoring, verification, and labeling technologies, thereby guaranteeing adherence to stringent regulatory requirements and preserving product integrity. A notable example is Omnicell Inc., a US-based healthcare technology company, which launched IVX Station in March 2023. This robotic compounding system automates sterile compounding operations within an ISO Class 5 environment. Its capabilities include continuous monitoring of temperature, humidity, and particles, alongside sophisticated vision systems, gravimetric verification, automatic labeling, and the automated placement of tamper-evident syringe caps. Furthermore, the system benefits from a continuously updated cloud-based formulation library, providing scalable access to the most current authorized formulations and facilitating high-volume, secure, and efficient pharmacy workflows.
Who Are The Top Market Participants Influencing The Sterile Compounding Pharmacies Market?
Major companies operating in the sterile compounding pharmacies market are B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter’s House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.
Read the full sterile compounding pharmacies market report here:
What Are The Top-Performing Regions Within The Sterile Compounding Pharmacies Market?
North America was the dominant region in the sterile compounding pharmacies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sterile Compounding Pharmacies Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12073&type=smp
Browse Through More Reports Similar to the Global Sterile Compounding Pharmacies Market 2026, By The Business Research Company
Sterile Medical Packaging Global Market Report
https://www.thebusinessresearchcompany.com/report/sterile-medical-packaging-global-market-report
Pharmacies And Drug Stores Global Market Report
https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report
Depyrogenated Sterile Empty Vials Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model